Insider · CIK 0001677513
Dale Broadrick
Files at BRTX (BioRestorative Therapies, Inc.). First filing Nov 5, 2024, latest Nov 5, 2024.
Dale Broadrick files SEC Form 4 as 10% owner at BRTX (BioRestorative Therapies, Inc.). Since Nov 5, 2024, Dale Broadrick has reported 0 open-market buys worth $0 and 1 open-market sell worth $1,757, the latest filed on Nov 5, 2024.
A track record needs three past buys with six months of prices behind them; Dale Broadrick has 0, so none is measured yet.
The newest scored trade: sold $1,757 of BRTX on Oct 28, 2024, filed Nov 5, 2024, scored 12 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BRTX: BioRestorative Therapies, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 12Weak | BRTXsell BioRestorative Therapies, Inc. | $1,757 1,112 shares | -0% | - |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 28, 2024 | BRTX BioRestorative Therapies, Inc. | SOpen-market sale Common Stock | -1,112 | $1.58 | $1,757 | 445,933 | Nov 5, 2024 |
Questions about Dale Broadrick
Answered from the filings on this page, as of the latest one.
Is Dale Broadrick buying or selling?
Not in the last 12 months. Dale Broadrick's latest open-market trade on SEC Form 4 was sold $1,757 of BRTX on Oct 28, 2024.
How did Dale Broadrick's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dale Broadrick has 0.
Where does Dale Broadrick file Form 4?
Dale Broadrick has filed Form 4 at BRTX (BioRestorative Therapies, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.